R&D Systems Inc. Tocris Bioscience Boston Biochem

UCL 2077

Cat. No. 2661

UCL 2077 C25H22N2 [918311-87-2]

Price and Availability

For UCL 2077 pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: N-Trityl-3-pyridinemethanamine

Biological Activity

Slow afterhyperpolarization (sAHP) channel blocker; reduces sAHP in hippocampal slice preparations. Displays no effect on Ca2+ currents or the time course of sAHP/sIAHP.

Technical Data

M.Wt:
350.46
Formula:
C25H22N2
Solubility:
Soluble to 50 mM in DMSO and to 25 mM in ethanol
Purity:
>99 %
Storage:
Store at RT
CAS No:
918311-87-2

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Safety Data Sheet: View Safety Data Sheet

References

Shah et al (2006) Enhancement of hippocampal pyramidal cell excitability by the novel selective slow-afterhyperpolarization channel blocker 3-(triphenylmethylaminomethyl)pyridine (UCL2077). Mol.Pharmacol. 70 1494. PMID: 16877678.

If you know of a relevant citation for this product please let us know.

Keywords: UCL 2077, supplier, Slow, hyperpolarization, sAHP, channels, blockers, Potassium, KCa, Channels, ca2+-activated, ca2+-dependent, K+, UCL2077

Quick Order

Find multiple products by catalog number

divider line

New Product E-alerts

Sign up for email updates from Tocris

Sign-up for New Product E-alerts

Enter your email address below to sign up to receive our email updates:

divider line

New Products in this Area

NS 6180

Potent KCa3.1 channel blocker

ADWX 1

Potent and selective KV1.3 channel blocker

Cesium chloride

Potassium channel blocker; neuroprotective

Sign-up for new product e-alerts
divider line

Tocris Events

Meet your representative

R&D Symposium 2013

The Role of Cytokines and Signaling in Inflammation

October 15, 2013

Bonn, Germany